ROR1 and B-cell non-Hodgkin lymphoma: Another anti-ROR1 antibody drug conjugate, consisting of the huXBR1-402 antibody conjugated with anthracycline derivative (PNU) showed inhibitory effect on ROR1 positive B-cell lymphoma in vivo and MCL in vitro [110, 111].